Decreased miR-29b levels in CTCL patients’ CD4 (+) T cells resulted in BRD4 overexpression, which was associated with elevated levels of the interleukin-15 (IL-15) receptor complex and tumor-related genes (including RBPJ and NOTCH1). Here, BRD4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.